H-DL-Leu-NH2 · HCl

H-DL-Leu-NH2 · HCl is a hydrochloride salt of the amino acid derivative corresponding to leucine in the DL stereochemical form, featuring a branched isobutyl side chain and an amino group at the α-position. The presence of the protonated amine as the HCl salt increases water compatibility and affects salt-mediated handling during peptide coupling and derivatization steps. The compound's primary amino functionality and carboxyl-less structure make it a direct nitrogen-bearing building block for amide formation, reductive amination, and salt-stabilized intermediate preparation. The DL designation indicates racemic stereochemistry at the chiral center, which can be intentionally used for method development, analytical standards, or downstream conversion into enantiopure derivatives via chiral resolution strategies.

1. Protected Amino Building Blocks

H-DL-Leu-NH2 · HCl functions as a nitrogenous leucine building block for protected amino acid synthesis workflows where an N-protected leucine equivalent is required. The α-amino group can be converted into common peptide-compatible protection states, while the branched hydrophobic side chain supports incorporation into amide-linked frameworks without introducing additional reactive heteroatoms. Salt formation with HCl enables controlled handling of the amino group prior to coupling chemistry, including formation of carbamates or amide derivatives that align with standard peptide synthesis protocols. Downstream use frequently includes preparing N-protected leucine intermediates for peptide bond construction, fragment assembly, and library synthesis routes that require leucine-derived stereochemical or structural motifs.

2. Peptide Coupling Chemistry

H-DL-Leu-NH2 · HCl is applicable to peptide coupling chemistry in contexts where leucine-derived amide linkages are formed through amine activation or nucleophilic acyl substitution. The primary amino group participates in forming amide bonds with activated carboxylic acid derivatives, enabling construction of leucine-containing peptide fragments and peptidomimetic scaffolds. The isobutyl side chain provides a hydrophobic recognition element that can influence conformational preferences in short peptides and SAR-oriented analog series. Racemic stereochemistry can be leveraged for method screening, generating comparative mixtures, or serving as a precursor for stereochemical enrichment when coupled with chiral separation or asymmetric downstream transformations.

3. Chemical Biology Labeling

H-DL-Leu-NH2 · HCl can be employed in chemical biology research for generating leucine-based probes and tagging handles that rely on amine reactivity. The α-amino functionality supports conjugation strategies such as formation of urea or amide linkages with activated carboxylates, as well as incorporation into linkers for biomolecule labeling. The hydrophobic leucine side chain can help tune solubility and noncovalent interactions of labeled constructs, which may be relevant when designing affinity probes or membrane-associated peptide fragments. The HCl salt form facilitates reproducible amine availability for downstream derivatization, supporting preparation of labeled intermediates for biochemical assays, protein modification studies, and analytical method development.

4. Analytical Standards And Methods

H-DL-Leu-NH2 · HCl is suitable for analytical research as a racemic leucine amino building block for method validation, chromatographic reference materials, and derivatization-based quantitation workflows. The defined amino salt composition provides a consistent chemical identity for calibration of amino analysis, derivatization reagent screening, and mass spectrometric response checks. The DL stereochemical mixture can be intentionally used to evaluate stereospecific derivatization or to benchmark chiral separation performance when converting the amino center into derivative forms. Downstream analytical utility can include preparation of derivatized leucine standards, internal standards for peptide hydrolysate analysis, and reference compounds for monitoring amino acid incorporation in synthetic or bioprocess streams.

5. Pharmaceutical Intermediate Preparation

H-DL-Leu-NH2 · HCl serves as an amino intermediate in fine chemical and pharmaceutical intermediate preparation where leucine-derived nitrogen fragments are required. The primary amino group can be transformed into protected forms compatible with multistep synthesis, including conversion into N-protected derivatives used in amide-forming steps toward drug-like scaffolds and peptide-like intermediates. The branched aliphatic side chain contributes a defined hydrophobic substituent pattern that is commonly carried through medicinal chemistry sequences and SAR exploration. Racemic starting material can be used for process development routes that later incorporate chiral resolution or asymmetric conversion, supporting industrially relevant synthesis planning for amino acid-derived building blocks.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics